| Product Code: ETC7538852 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Burkitt lymphoma market import shipments experienced significant growth with a CAGR of 30.4% from 2020 to 2024. The growth momentum accelerated notably between 2023 and 2024, surging by 445.1%. The market exhibited a robust expansion trend, indicating a thriving demand for imported products in this segment.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Burkitt Lymphoma Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Burkitt Lymphoma Market Revenues & Volume, 2021 & 2031F |
3.3 India Burkitt Lymphoma Market - Industry Life Cycle |
3.4 India Burkitt Lymphoma Market - Porter's Five Forces |
3.5 India Burkitt Lymphoma Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 India Burkitt Lymphoma Market Revenues & Volume Share, By Company Name, 2021 & 2031F |
4 India Burkitt Lymphoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Burkitt lymphoma in India |
4.2.2 Growing research and development activities in the field of oncology |
4.2.3 Improvements in healthcare infrastructure and access to advanced treatments in India |
4.3 Market Restraints |
4.3.1 High treatment costs and limited insurance coverage for Burkitt lymphoma therapies |
4.3.2 Lack of skilled healthcare professionals specialized in treating Burkitt lymphoma in India |
4.3.3 Challenges in timely diagnosis and access to appropriate treatment options in remote areas |
5 India Burkitt Lymphoma Market Trends |
6 India Burkitt Lymphoma Market, By Types |
6.1 India Burkitt Lymphoma Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 India Burkitt Lymphoma Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 India Burkitt Lymphoma Market Revenues & Volume, By Cyclophosphamide oral, 2021- 2031F |
6.1.4 India Burkitt Lymphoma Market Revenues & Volume, By Rituxan (Rituximab), 2021- 2031F |
6.1.5 India Burkitt Lymphoma Market Revenues & Volume, By Brexucabtageneautoleucel, 2021- 2031F |
6.1.6 India Burkitt Lymphoma Market Revenues & Volume, By Sepantronium Bromide, 2021- 2031F |
6.1.7 India Burkitt Lymphoma Market Revenues & Volume, By ADCT402, 2021- 2031F |
6.2 India Burkitt Lymphoma Market, By Company Name |
6.2.1 Overview and Analysis |
6.2.2 India Burkitt Lymphoma Market Revenues & Volume, By Hikma Pharmaceuticals, 2021- 2031F |
6.2.3 India Burkitt Lymphoma Market Revenues & Volume, By Biogen Idec/Genentech, 2021- 2031F |
6.2.4 India Burkitt Lymphoma Market Revenues & Volume, By Kite Pharma, 2021- 2031F |
6.2.5 India Burkitt Lymphoma Market Revenues & Volume, By Cothera Bioscience, 2021- 2031F |
7 India Burkitt Lymphoma Market Import-Export Trade Statistics |
7.1 India Burkitt Lymphoma Market Export to Major Countries |
7.2 India Burkitt Lymphoma Market Imports from Major Countries |
8 India Burkitt Lymphoma Market Key Performance Indicators |
8.1 Patient survival rates following Burkitt lymphoma treatment |
8.2 Adoption rates of innovative therapies for Burkitt lymphoma in India |
8.3 Number of clinical trials and research studies focused on Burkitt lymphoma in the Indian market |
9 India Burkitt Lymphoma Market - Opportunity Assessment |
9.1 India Burkitt Lymphoma Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 India Burkitt Lymphoma Market Opportunity Assessment, By Company Name, 2021 & 2031F |
10 India Burkitt Lymphoma Market - Competitive Landscape |
10.1 India Burkitt Lymphoma Market Revenue Share, By Companies, 2024 |
10.2 India Burkitt Lymphoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here